Newamsterdam Pharma Co NV to Showcase Innovations at Global Healthcare Conference
Newamsterdam Pharma Co NV, a late-stage biopharmaceutical company, is set to present at the 2025 RBCCM Global Healthcare Conference, showcasing its oral small molecule therapies for cardiovascular and metabolic diseases.
2 minutes to read